Canton Strategic Holdings Inc (CNTN) vs Oramed Pharmaceuticals Inc. (ORMP)
A side-by-side comparison of Canton Strategic Holdings Inc and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTN
Canton Strategic Holdings Inc
$2.41HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
ORMP
Oramed Pharmaceuticals Inc.
$4.45HealthcareDelayed quote: Oct 6, 2026, 12:13 PM EDT
Total return — CNTN vs ORMP
growth of $100 · dividends reinvested · last 5yCNTN -99.8% (-71.8%/yr)ORMP -59.8% (-16.7%/yr)ORMP compounded faster over this window
Log scale — wide-divergence pair
CNTN ORMP
CNTN vs ORMP: by the numbers
- •CNTN is the larger company ($186M vs $182M market cap).
- •ORMP is profitable (3202.50% net margin) while CNTN runs a net loss (-6559.27%).
- •ORMP pays a dividend (5.59% yield), while CNTN has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CNTN | ORMP |
|---|---|---|
| P/E ratio | N/A | 1.08 |
| Forward P/E | N/A | 1.00 |
| P/S ratio | 124.25 | N/A |
| P/B ratio | 0.41 | 0.57 |
Profitability
| Metric | CNTN | ORMP |
|---|---|---|
| Gross margin | 0.00% | 0.65% |
| Operating margin | 0.00% | -754.40% |
| Net margin | -6559.27% | 3202.50% |
| ROE | -21.57% | 55.08% |
| ROIC | -9.57% | -3.21% |
Dividends
| Metric | CNTN | ORMP |
|---|---|---|
| Dividend yield | N/A | 5.59% |
| Payout ratio | N/A | 6.08% |
Growth (annualized)
| Metric | CNTN | ORMP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -25.80% |
Frequently asked
- Does CNTN or ORMP pay a bigger dividend?
- ORMP pays a dividend (5.59% yield), while CNTN has no payments in the available dividend history.
- Is CNTN or ORMP more profitable?
- ORMP runs the higher net margin — CNTN at -6559.27% versus ORMP at 3202.50%.
Go deeper
Dig into the metrics
Oramed Pharmaceuticals P/E ratioOramed Pharmaceuticals dividend yieldCanton Strategic ROEOramed Pharmaceuticals ROECanton Strategic operating marginOramed Pharmaceuticals operating marginCanton Strategic revenue growthOramed Pharmaceuticals revenue growthCanton Strategic free cash flowOramed Pharmaceuticals free cash flow
Canton Strategic & Oramed Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.